Effects of Ivabradine on Residual Myocardial Ischemia After PCI

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 5, 2015

Primary Completion Date

March 7, 2017

Study Completion Date

March 7, 2017

Conditions

Angina Pectoris, Stable

Interventions

DRUG

Ivabradine

Ivabradine 5 mg twice a day

Trial Locations (1)

Massimo Mancone, Rome

All Listed Sponsors

lead

Azienda Policlinico Umberto I

OTHER

NCT03866395 - Effects of Ivabradine on Residual Myocardial Ischemia After PCI | Biotech Hunter | Biotech Hunter